S.Africa to host phase 2 AIDS vaccine trials (Reuters)


Reuters - South Africa's first Phase II HIV
vaccine trials intended to help battle an AIDS epidemic were
launched by charitable group the International AIDS Vaccine
Initiative (IAVI) and U.S.-based Targeted Genetics Corporation.